About

12
Oct

Philips to expand its image-guided therapy devices portfolio through acquisition of Intact Vascular

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire Intact Vascular, Inc., a Honolulu, Hawaii based developer of medical devices for minimally-invasive peripheral vascular procedures. Intact Vascular will enhance Philips’ image-guided therapy portfolio, combining Philips͛ interventional imaging platform and diagnostic and therapeutic devices with Intact Vascular’s unique, specialized implantable device to optimize the treatment of patients with Peripheral Artery Disease (PAD).

PAD develops when plaque builds up in arteries and reduces blood flow to the limbs, most commonly the legs. It affects more than 200 million people worldwide [1]. PAD symptoms include recurrent fatigue, leg pain, and foot or leg wounds that do not heal or heal very slowly. Critical Limb Ischemia (CLI) is an advanced stage of PAD, and is typically associated with high rates of amputation and mortality.

“Acquiring Intact Vascular will expand our portfolio of minimally invasive therapy options for Peripheral Artery Disease with the Tack Endovascular System [2], a much needed implant that effectively restores blood flow in small limb vessels, promotes healing and preserves limbs͕͟ said Chris Landon, Senior Vice President and General Manager Image Guided Therapy Devices at Philips͘ ͞Through the integration of our interventional imaging systems and diagnostic and therapeutic devices, we will be able to provide clinicians with a complete procedural solution to optimize the treatment of patients with this disease.”

Click here to read more about the acquisition at philips.com.

About Sennet Capital

Comments are closed.